OpenURL Connection Search

Select item for more details and to access through your institution.

A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
Published in:
Digestive Diseases & Sciences, 2024, v. 69, n. 6, p. 2165, doi. 10.1007/s10620-024-08410-z
By:
- van Linschoten, Reinier C. A.;
- Jansen, Fenna M.;
- Pauwels, Renske W. M.;
- Smits, Lisa J. T.;
- Atsma, Femke;
- Kievit, Wietske;
- de Jong, Dirk J.;
- de Vries, Annemarie C.;
- Boekema, Paul J.;
- West, Rachel L.;
- Bodelier, Alexander G. L.;
- Gisbertz, Ingrid A. M.;
- Wolfhagen, Frank H. J.;
- Römkens, Tessa E. H.;
- Lutgens, Maurice W. M. D.;
- van Bodegraven, Adriaan A.;
- Oldenburg, Bas;
- Pierik, Marieke J.;
- Russel, Maurice G. V. M.;
- de Boer, Nanne K.
Publication type:
Article
Depressive Symptoms in Crohn's Disease: Relationship with Immune Activation and Tryptophan Availability.
Published in:
PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0060435
By:
- Guloksuz, Sinan;
- Wichers, Marieke;
- Kenis, Gunter;
- Russel, Maurice G. V. M.;
- Wauters, Annick;
- Verkerk, Robert;
- Arts, Baer;
- van Os, Jim
Publication type:
Article
Inflammatory bowel disease patients provide reliable self‐reported medical information: A multicentre prospective pharmacovigilance monitoring system.
Published in:
Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 4, p. 520, doi. 10.1002/pds.5175
By:
- Thomas, Pepijn W. A.;
- West, Rachel L.;
- Russel, Maurice G. V. M.;
- Jansen, Jeroen M.;
- Kosse, Leanne J.;
- Jessurun, Naomi T.;
- Römkens, Tessa E. H.;
- Hoentjen, Frank
Publication type:
Article
External Validity and Consistency over Time of Patient Segmentation Based on Disease Acceptance and Perceived Control in Inflammatory Bowel Disease.
Published in:
Journal of Gastrointestinal & Liver Diseases, 2023, v. 32, n. 3, p. 306, doi. 10.15403/jgld-4855
By:
- van Erp, Liselot W.;
- Thomas, Pepijn W. A.;
- Groenen, Marcel J. M.;
- Bloem, Sjaak;
- Russel, Maurice G. V. M.;
- Römkens, Tessa E. H.;
- Wahab, Peter J.
Publication type:
Article
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial.
Published in:
Journal of Crohn's & Colitis, 2023, v. 17, n. 11, p. 1771, doi. 10.1093/ecco-jcc/jjad101
By:
- Jansen, Fenna M;
- Linschoten, Reinier C A van;
- Kievit, Wietske;
- Smits, Lisa J T;
- Pauwels, Renske W M;
- Jong, Dirk J de;
- Vries, Annemarie C de;
- Boekema, Paul J;
- West, Rachel L;
- Bodelier, Alexander G L;
- Gisbertz, Ingrid A M;
- Wolfhagen, Frank H J;
- Römkens, Tessa E H;
- Lutgens, Maurice W M D;
- Bodegraven, Adriaan A van;
- Oldenburg, Bas;
- Pierik, Marieke J;
- Russel, Maurice G V M;
- Boer, Nanne K de;
- Mallant-Hent, Rosalie C
Publication type:
Article
Safety of Tioguanine During Pregnancy in Inflammatory Bowel Disease.
Published in:
Journal of Crohn's & Colitis, 2016, v. 10, n. 2, p. 159, doi. 10.1093/ecco-jcc/jjv189
By:
- van den Berg, Sophie A.;
- de Boer, Marjon;
- van der Meulen-de Jong, Andrea E.;
- Jansen, Jeroen M.;
- Hoentjen, Frank;
- Russel, Maurice G. V. M.;
- Mahmmod, Nofel;
- van Bodegraven, Adriaan A.;
- van der Woude, C. Janneke;
- Mulder, Chris J. J.;
- de Boer, Nanne K. H.
Publication type:
Article
Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry.
Published in:
Drug Safety, 2021, v. 44, n. 5, p. 581, doi. 10.1007/s40264-021-01045-3
By:
- Giraud, Eline L.;
- Thomas, Pepijn W. A.;
- van Lint, Jette A.;
- van Puijenbroek, Eugene P.;
- Römkens, Tessa E. H.;
- West, Rachel L.;
- Russel, Maurice G. V. M.;
- Jansen, Jeroen M.;
- Jessurun, Naomi T.;
- Hoentjen, Frank
Publication type:
Article

Found: 7

A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.

Depressive Symptoms in Crohn's Disease: Relationship with Immune Activation and Tryptophan Availability.

Inflammatory bowel disease patients provide reliable self‐reported medical information: A multicentre prospective pharmacovigilance monitoring system.

External Validity and Consistency over Time of Patient Segmentation Based on Disease Acceptance and Perceived Control in Inflammatory Bowel Disease.

Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial.

Safety of Tioguanine During Pregnancy in Inflammatory Bowel Disease.

Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry.